文献速递胃肠外科围术期管理与 ERAS

机器人辅助经腹入路单独或联合经肛入路行低位直肠癌侧方淋巴结清扫的短期手术结局比较

Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach.
PubMed 文献 · Surg Endosc · 2024-03-04

本研究回顾性纳入2019年6月至2023年5月诊断为低位直肠癌的39例患者,比较机器人辅助经腹入路单独行侧方淋巴结清扫(经腹组,n=19)与联合经肛入路(双团队组,n=20)的短期手术结局。双团队组总手术时间和单侧侧方淋巴结清扫时间均显著短于经腹组,术中出血量显著更少,术后并发症及排尿障碍发生率两组无显著差异(均为5%)。

要点

  • 双团队组总手术时间366分钟 vs 经腹组513分钟(P<0.001),单侧侧方淋巴结清扫时间64分钟 vs 114分钟(P<0.001)。
  • 双团队组术中出血量30 mL vs 经腹组80 mL(P=0.004)。
  • 两组术后并发症无显著差异,术后排尿障碍发生率均为5%。

核心结论

  • 机器人辅助经腹入路行侧方淋巴结清扫时,联合经肛入路可缩短手术时间。
  • 两组术后排尿障碍发生率均较低。
  • 作者认为,机器人辅助经腹侧方淋巴结清扫联合经肛入路可作为晚期低位直肠癌有前景的治疗选择。

研究设计与样本

  • 回顾性纳入2019年6月至2023年5月诊断为低位直肠癌的39例患者。
  • 按侧方淋巴结清扫入路分为经腹组(机器人辅助经腹入路单独,n=19)和双团队组(联合经肛入路,n=20)。
  • 比较两组患者特征和短期手术结局。

主要发现

  • 双团队组总手术时间366分钟 vs 经腹组513分钟(P<0.001)。
  • 双团队组单侧侧方淋巴结清扫时间64分钟 vs 经腹组114分钟(P<0.001)。
  • 双团队组术中出血量30 mL vs 经腹组80 mL(P=0.004)。
  • 两组术后并发症无显著差异。
  • 两组术后排尿障碍发生率均为5%。

临床怎么用

  • 作者认为,机器人辅助经腹侧方淋巴结清扫联合经肛入路可作为晚期低位直肠癌有前景的治疗选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lateral lymph node metastases are a major cause of local recurrence after surgery for advanced low rectal cancer. Lateral lymph node dissection (LLND) may reduce the risk of local recurrence in patients with suspected lateral lymph node metastasis. Recent reports have shown that robotic-assisted LLND can help to reduce the postoperative complication rate, such as urinary disturbance. Furthermore, with the advent of transanal total mesorectal excision, a novel LLND procedure that combines a transabdominal approach with a transanal approach has been reported. This study aimed to clarify the safety and feasibility of robotic-assisted LLND supported by a transanal approach for advanced low rectal cancer. METHODS: Thirty-nine patients diagnosed to have low rectal cancer between June 2019 and May 2023 were retrospectively enrolled and divided according to whether they underwent LLND via a robotic-assisted transabdominal approach alone (transabdominal group, n = 19) or in combination with a transanal approach (2team group, n = 20). The patient characteristics and short-term surgical outcomes were compared between the two groups. RESULTS: The total operation time was significantly shorter in the 2team group than in the transabdominal group (366 min vs. 513 min, P < 0.001), as was the time taken to perform unilateral LLND (64 min vs. 114 min, P < 0.001). Furthermore, there was significantly less intraoperative bleeding in the 2team group (30 mL vs. 80 mL, P = 0.004). There was no significant between-group difference in postoperative complications. The incidence of postoperative urinary disturbance was satisfactory at 5% in both groups. CONCLUSIONS: The operation time for LLND performed by a robotic-assisted transabdominal approach was shortened when supported by a transanal approach. The frequency of postoperative urinary disturbance was low in both groups. Therefore, robotic-assisted abdominal LLND supported by a transanal approach can be considered a promising treatment option for advanced low rectal cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Tokunaga T, Kashihara H, Yoshikawa K, et al. Comparison of the short-term surgical outcomes of lateral lymph node dissection for low rectal cancer using a robotic-assisted transabdominal approach alone or supported by a transanal approach. Surg Endosc. 2024. PMID: 38438675. doi:10.1007/s00464-024-10730-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。